- Home
- NIU vs SLRN Comparison
NIU vs SLRN Comparison
Compare NIU & SLRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NIU
- SLRN
- Stock Information
- Founded
- NIU 2014
- SLRN 2020
- Country
- NIU China
- SLRN United States
- Employees
- NIU N/A
- SLRN N/A
- Industry
- NIU Auto Manufacturing
- SLRN Biotechnology: Pharmaceutical Preparations
- Sector
- NIU Consumer Discretionary
- SLRN Health Care
- Exchange
- NIU Nasdaq
- SLRN Nasdaq
- Market Cap
- NIU 216.7M
- SLRN 224.6M
- IPO Year
- NIU 2018
- SLRN 2023
- Fundamental
- Price
- NIU $3.35
- SLRN $2.36
- Analyst Decision
- NIU
- SLRN Hold
- Analyst Count
- NIU 0
- SLRN 5
- Target Price
- NIU N/A
- SLRN $9.60
- AVG Volume (30 Days)
- NIU 902.6K
- SLRN 703.6K
- Earning Date
- NIU 05-19-2025
- SLRN 05-16-2025
- Dividend Yield
- NIU N/A
- SLRN N/A
- EPS Growth
- NIU N/A
- SLRN N/A
- EPS
- NIU N/A
- SLRN N/A
- Revenue
- NIU $450,507,095.00
- SLRN N/A
- Revenue This Year
- NIU $36.24
- SLRN $267.11
- Revenue Next Year
- NIU $24.04
- SLRN N/A
- P/E Ratio
- NIU N/A
- SLRN N/A
- Revenue Growth
- NIU 24.00
- SLRN N/A
- 52 Week Low
- NIU $1.65
- SLRN $1.85
- 52 Week High
- NIU $4.90
- SLRN $7.25
- Technical
- Relative Strength Index (RSI)
- NIU 50.22
- SLRN 47.93
- Support Level
- NIU $3.51
- SLRN $2.34
- Resistance Level
- NIU $3.68
- SLRN $2.64
- Average True Range (ATR)
- NIU 0.23
- SLRN 0.17
- MACD
- NIU 0.01
- SLRN 0.02
- Stochastic Oscillator
- NIU 52.69
- SLRN 48.70
About NIU Niu Technologies
Niu Technologies designs, manufactures and sells high-performance electric motorcycles, scooters, bicycles, and kick-scooters. The company has a product portfolio consisting of electric motorcycle, mopeds and bicycle series, including the NQi, MQi, UQi, F series, and others, and micro-mobility series, including the kick-scooter series KQi and the e-bike series BQi. The company's principal operations and geographic markets are predominantly in the People's Republic of China. It also generates revenue from Europe and other regions.
About SLRN ACELYRIN INC.
Acelyrin Inc is a late-stage clinical biopharmaceutical company. The clinical biopharma segment researches and develops treatments for diseases with pathology related to excess activation of the immune system. It is focused on providing patients with life-changing new treatment options by identifying, acquiring, and accelerating the development and commercialization of transformative medicines.